Therapeutic potential of terbinafine in subcutaneous and systemic mycoses
- 1 November 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 141 (s56) , 36-40
- https://doi.org/10.1046/j.1365-2133.1999.00013.x
Abstract
Mycoses vary widely in severity, and may present as superficial, subcutaneous and/or systemic infection. Effective treatments for most superficial mycoses now exist, but new agents with convenient do...Keywords
This publication has 9 references indexed in Scilit:
- In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicansJournal of Antimicrobial Chemotherapy, 1998
- In vitro activity of terbinafine (Lamisilr`): An updateJournal of Dermatological Treatment, 1998
- A multicentre trial of terbinafine in patients with chromoblastomycosis: Effect on clinical and biological criteriaJournal of Dermatological Treatment, 1998
- Relapsing Aspergillus Bronchitis in a Double Lung Transplant Patient, Successfully Treated With a New Oral Antimycotic AgentChest, 1997
- Employment of terbinafine against Pneumocystis carinii infection in rat modelsBritish Journal of Dermatology, 1996
- Successful treatment of cutaneous sporotrichosis with terbinafineJournal of Dermatological Treatment, 1996
- A Case of Sporotrichosis Successfully Treated with Terbinafine.The Nishinihon Journal of Dermatology, 1994
- Treatment of cutaneous sporotrichosis with terbinafineBritish Journal of Dermatology, 1992
- In-vitro studies with SF 86–327, a new orally active allylamine derivativeMedical Mycology, 1985